{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:31:24Z","timestamp":1754145084306,"version":"3.41.2"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cld.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:30:41Z","timestamp":1747899041000},"page":"503-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatopulmonary Syndrome and Portopulmonary Hypertension"],"prefix":"10.1016","volume":"29","author":[{"given":"Esli","family":"Medina-Morales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cld.2025.03.004_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"issue":"38","key":"10.1016\/j.cld.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.cld.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrcardio.2017.84","article-title":"Epidemiology and treatment of pulmonary arterial hypertension","volume":"14","author":"Lau","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.cld.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cld.2022.08.002","article-title":"Portopulmonary hypertension","volume":"27","author":"Lai","year":"2023","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2025.03.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2024.03.005","article-title":"Pulmonary complications of portal hypertension","author":"Bommena","year":"2024","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.cld.2025.03.004_bib7","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/TP.0000000000003490","article-title":"Clinical outcomes after liver transplantation in patients with portopulmonary hypertension","volume":"105","author":"Cartin-Ceba","year":"2021","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2025.03.004_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MOT.0b013e32834664df","article-title":"Pulmonary complications in cirrhosis","volume":"16","author":"Sussman","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2025.03.004_bib10","first-page":"1","article-title":"Prevalence and prognosis of portopulmonary hypertension in 223 liver transplant recipients","volume":"2018","author":"Li","year":"2018","journal-title":"Can Respir J J Can Thorac Soc"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2025.03.004_bib14","article-title":"Portopulmonary hypertension: from bench to bedside","volume":"7","author":"Thomas","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cld.2025.03.004_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1142836","article-title":"Current clinical understanding and effectiveness of portopulmonary hypertension treatment","volume":"10","author":"Tamura","year":"2023","journal-title":"Front Med"},{"issue":"10","key":"10.1016\/j.cld.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12 Suppl S","key":"10.1016\/j.cld.2025.03.004_bib17","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","volume":"43","author":"Barst","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1089253207301355","article-title":"Clinical presentation, differential diagnosis, and vasodilator testing of pulmonary hypertension","volume":"11","author":"Edelman","year":"2007","journal-title":"Semin CardioThorac Vasc Anesth"},{"issue":"20","key":"10.1016\/j.cld.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/CIRCULATIONAHA.114.006971","article-title":"Clinical diagnosis of pulmonary hypertension","volume":"130","author":"Rich","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.30817","article-title":"Congenital extrahepatic portosystemic shunts (abernethy malformation): an international observational study","volume":"71","author":"Baiges","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib21","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jpedsurg.2007.11.001","article-title":"Resolution of hepatopulmonary syndrome after ligation of a portosystemic shunt in a pediatric patient with an abernethy malformation","volume":"43","author":"Morikawa","year":"2008","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3346\/jkms.2014.29.4.604","article-title":"A case of pulmonary arterial hypertension associated with congenital extrahepatic portocaval shunt","volume":"29","author":"Yi","year":"2014","journal-title":"J Kor Med Sci"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPG.0b013e31828b3750","article-title":"Congenital portosystemic shunt: characterization of a multisystem disease","volume":"56","author":"Sokollik","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American association for the study of liver diseases and the American society of transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcmg.2012.11.002","article-title":"Echocardiography in liver transplant candidates","volume":"6","author":"Garg","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cld.2025.03.004_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.cld.2025.03.004_bib28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.cld.2025.03.004_bib29","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.mayocp.2022.08.020","article-title":"Portopulmonary hypertension in nontransplanted patients: results of the largest US single-institution registry","volume":"97","author":"Cajigas","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.cld.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00534-009-0255-7","article-title":"Poor outcome following aborted orthotopic liver transplantation due to severe porto-pulmonary hypertension","volume":"17","author":"Fukazawa","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pcad.2012.08.002","article-title":"Anesthesia and pulmonary hypertension","volume":"55","author":"McGlothlin","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib34","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000542-199412000-00031","article-title":"Nitric oxide reduces pulmonary hypertension during hepatic transplantation","volume":"81","author":"Mandell","year":"1994","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.cld.2025.03.004_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001085","article-title":"Outcomes of liver transplantation in treated portopulmonary hypertension patients with a mean pulmonary arterial pressure \u226535 mm Hg","volume":"6","author":"DuBrock","year":"2020","journal-title":"Transplant Direct"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0000000000003248","article-title":"Long-term outcomes and survival in moderate-severe portopulmonary hypertension after liver transplant","volume":"105","author":"Sadd","year":"2021","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2025.03.004_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001586","article-title":"The clinical course of portopulmonary hypertension and outcomes with endothelin receptor antagonist treatment: observational study of data from the US organ procurement and transplantation network","volume":"10","author":"DuBrock","year":"2024","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1016\/j.cld.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0000000000001981","article-title":"Does portopulmonary hypertension impede liver transplantation in cirrhotic patients? A French multicentric retrospective study","volume":"102","author":"Reymond","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.transproceed.2016.12.006","article-title":"Comparison of post-liver transplantation outcomes in portopulmonary hypertension and pulmonary venous hypertension: a single-center experience","volume":"49","author":"Rajaram","year":"2017","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.cld.2025.03.004_bib41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.28990","article-title":"Long-term outcome in liver transplantation candidates with portopulmonary hypertension","volume":"65","author":"Savale","year":"2017","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2025.03.004_bib43","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/lt.24625","article-title":"Portopulmonary hypertension: still an appropriate consideration for liver transplantation?","volume":"22","author":"Verma","year":"2016","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.cld.2025.03.004_bib44","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s10620-014-3065-y","article-title":"Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era","volume":"59","author":"Salgia","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib45","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1600-6143.2006.01701.x","article-title":"The impact of treatment of portopulmonary hypertension on survival following liver transplantation","volume":"7","author":"Ashfaq","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/lt.21713","article-title":"Pulmonary hypertension after liver transplantation: case presentation and review of the literature","volume":"15","author":"Koch","year":"2009","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1034\/j.1600-6143.2002.20913.x","article-title":"De novo diagnosis of portopulmonary hypertension following liver transplantation: pulmonary hypertension following liver transplantation","volume":"2","author":"Koneru","year":"2002","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.cld.2025.03.004_bib48","article-title":"Hepatopulmonary syndrome","volume":"4","author":"Raevens","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib49","first-page":"1047","article-title":"Pulmonary complications of the liver","volume":"56","author":"Sabate","year":"2024","journal-title":"Curr Hepatol Rep"},{"issue":"3","key":"10.1016\/j.cld.2025.03.004_bib50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/HEP.0000000000000605","article-title":"Physiologic changes in the hepatopulmonary syndrome before and after liver transplant: a longitudinal and predictor analysis","volume":"79","author":"Zhao","year":"2024","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib51","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0016-5085(95)90589-8","article-title":"Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome","volume":"109","author":"Abrams","year":"1995","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib52","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s10620-011-1600-7","article-title":"Serial pulse oximetry in hepatopulmonary syndrome","volume":"56","author":"Kochar","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib53","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.26745","article-title":"Pulmonary complications in chronic liver disease","volume":"59","author":"Machicao","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib54","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.gastro.2008.06.038","article-title":"Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates","volume":"135","author":"Fallon","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.20658","article-title":"Natural history of hepatopulmonary syndrome: impact of liver transplantation","volume":"41","author":"Swanson","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2025.03.004_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/jhep.2003.50023","article-title":"Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation","volume":"37","author":"Arguedas","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib57","doi-asserted-by":"crossref","first-page":"1256.e1","DOI":"10.1053\/j.gastro.2014.01.005","article-title":"Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database","volume":"146","author":"Goldberg","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib58","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0016-5085(03)01207-1","article-title":"Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis","volume":"125","author":"Schenk","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2025.03.004_bib59","article-title":"Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: a systematic review","volume":"80","author":"Aragon Pinto","year":"2021","journal-title":"Respir Med Res"},{"issue":"1","key":"10.1016\/j.cld.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.gastro.2010.03.044","article-title":"Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease","volume":"139","author":"Roberts","year":"2010","journal-title":"Gastroenterology"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2025.03.004_bib61","first-page":"G779","article-title":"Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome","volume":"272","author":"Fallon","year":"1997","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib62","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.29579","article-title":"Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice","volume":"68","author":"Raevens","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0168-8278(03)00012-6","article-title":"Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome","volume":"38","author":"Luo","year":"2003","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib64","doi-asserted-by":"crossref","first-page":"L1467","DOI":"10.1152\/ajplung.00446.2006","article-title":"Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome","volume":"292","author":"Tang","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"10.1016\/j.cld.2025.03.004_bib65","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1440-1746.2005.03914.x","article-title":"Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome","volume":"20","author":"Sztrymf","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2025.03.004_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cld.2025.03.004_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113451","article-title":"Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS)","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.cld.2025.03.004_bib68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.resp.2011.10.001","article-title":"Respiratory mechanics and lung tissue remodeling in a hepatopulmonary syndrome rat model","volume":"179","author":"Melo-Silva","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/liv.12655","article-title":"Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury","volume":"35","author":"Chen","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib70","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0168-8278(99)80143-3","article-title":"Hepatopulmonary syndrome associated with cardiorespiratory disease","volume":"30","author":"Martinez","year":"1999","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib71","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/lt.24390","article-title":"Intrapulmonary vascular dilatations are common in portopulmonary hypertension and May be associated with decreased survival","volume":"22","author":"Fonseca","year":"2016","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2214\/ajr.166.6.8633451","article-title":"The hepatopulmonary syndrome: radiologic findings in 10 patients","volume":"166","author":"McAdams","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.cld.2025.03.004_bib73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0168-8278(00)00108-2","article-title":"Hepatopulmonary syndrome in candidates for liver transplantation","volume":"34","author":"Mart\u00ednez","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2025.03.004_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/(SICI)1522-726X(199905)47:1<64::AID-CCD15>3.0.CO;2-6","article-title":"Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management","volume":"47","author":"Cheng","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib75","first-page":"276","article-title":"Differential diagnosis of hepatopulmonary syndrome (HPS): portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT)","volume":"17","author":"Krynytska","year":"2017","journal-title":"Bosn J Basic Med Sci"},{"issue":"6","key":"10.1016\/j.cld.2025.03.004_bib76","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1183\/09031936.00104309","article-title":"Graded contrast echocardiography in pulmonary arteriovenous malformations","volume":"35","author":"Parra","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.cld.2025.03.004_bib77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1155\/2010\/349076","article-title":"The role of garlic in hepatopulmonary syndrome: a randomized controlled trial","volume":"24","author":"De","year":"2010","journal-title":"Can J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2025.03.004_bib78","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/hep4.1432","article-title":"High-dose oral garlic is associated with a decrease in intrapulmonary shunting in severe hepatopulmonary syndrome","volume":"3","author":"McClure","year":"2019","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.cld.2025.03.004_bib79","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/lt.25438","article-title":"Sorafenib in hepatopulmonary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Kawut","year":"2019","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib80","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cld.2019.06.003","article-title":"Pulmonary complications of portal hypertension","volume":"23","author":"Cartin-Ceba","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"12","key":"10.1016\/j.cld.2025.03.004_bib81","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/EJA.0b013e328365bb6f","article-title":"Hepatopulmonary syndrome: the anaesthetic considerations","volume":"30","author":"Fauconnet","year":"2013","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.004_bib82","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ajt.13177","article-title":"Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome: posttransplant hypoxemia management in HPS","volume":"15","author":"Nayyar","year":"2015","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib83","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/lt.23776","article-title":"Defining and characterizing severe hypoxemia after liver transplantation in hepatopulmonary syndrome: POST-LT hypoxemia in HPS","volume":"20","author":"Nayyar","year":"2014","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2025.03.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2022.100693","article-title":"Extracorporeal membrane oxygenation in patients with hepatopulmonary syndrome undergoing liver transplantation: a systematic review of the literature","volume":"36","author":"Wu","year":"2022","journal-title":"Transplant Rev"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326125000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326125000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:30:52Z","timestamp":1752676252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326125000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1089326125000200"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2025.03.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatopulmonary Syndrome and Portopulmonary Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}